- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 383 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 192 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- April 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 180 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- May 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 181 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 197 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 134 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- September 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- May 2024
- 137 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- September 2024
- 95 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP

The Anemia Drug market is a subset of the larger Hematological Drugs market, which includes drugs used to treat blood-related diseases. Anemia drugs are used to treat anemia, a condition in which the body does not produce enough healthy red blood cells. These drugs can be used to treat a variety of anemias, including iron deficiency anemia, aplastic anemia, and sickle cell anemia. Anemia drugs can be administered orally, intravenously, or intramuscularly, depending on the type of anemia being treated.
Common anemia drugs include erythropoietin, darbepoetin, and epoetin alfa. Erythropoietin is a hormone that stimulates the production of red blood cells, while darbepoetin and epoetin alfa are synthetic versions of erythropoietin. Other anemia drugs include iron supplements, folic acid, and vitamin B12.
Some companies in the Anemia Drug market include Amgen, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more